SCHEMBL868677

SCHEMBL868677

COC(=O)CCC(C)(C)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 1/20 0.50
CA12 O43570 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
AKT1 P31749 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
MMP8 P22894 3/20 0.43
CYP3A4 P08684 2/20 0.43
TSHR P16473 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LTA4H P09960 1/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP1A2 P05177 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11618178 0.85 ALDH1A1 (0.51) ALDH1A1LMNAKDM4ECA12CA7
SCHEMBL5750562 0.84 MMP8 (0.51) ALDH1A1TDP1MMP8LTA4HRECQL
SCHEMBL4952008 0.83 ALDH1A1 (0.49) ALDH1A1LMNAKDM4ECA12CA7
SCHEMBL4305663 0.83 ALDH1A1 (0.43) ALDH1A1LMNATDP1MMP8CYP3A4
SCHEMBL27550761 0.83 CA12 (0.47) ALDH1A1LMNAKDM4ECA12CA7
SCHEMBL27778793 0.83 CA12 (0.47) ALDH1A1LMNAKDM4ECA12CA7
SCHEMBL5750633 0.82 KEAP1 (0.50) ALDH1A1LMNAMMP8CYP3A4CYP2C9
SCHEMBL28044400 0.82 CA12 (0.49) ALDH1A1LMNAKDM4ECA12CA7
Ammonia Solution, Strong SCHEMBL28391244 0.81 ALDH1A1 (0.47) ALDH1A1LMNAKDM4ECA12CA7
SCHEMBL29662653 0.79 TDP1 (0.47) ALDH1A1LMNAKDM4ECA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 658 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704791-A1 ETHANOL-FREE FRAGRANCE MICROEMULSION Coty Inc. (US) 2026-03-11 EP claimed
US-20260013536-A1 FLAVOR COMPOSITION AND FOOD OR BEVERAGE TAKASAGO INTERNATIONAL CORPORATION (JP) 2026-01-15 US claimed
US-20250376643-A1 TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES ENCAPSYS, LLC (US) 2025-12-11 US claimed
EP-4627029-A1 TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES Encapsys, LLC (US) 2025-10-08 EP claimed
EP-4626387-A1 TREATMENT COMPOSITION WITH PERFUME CONTAINING DELIVERY PARTICLES The Procter & Gamble Company (US) 2025-10-08 EP claimed
US-12384990-B2 Treatment compositions comprising plant rosin material and certain perfume raw materials THE PROCTER & GAMBLE COMPANY (US) 2025-08-12 US claimed
EP-4563008-A1 FRAGRANCE COMPOSITION AND FOOD OR BEVERAGE Takasago International Corporation (JP) 2025-06-04 EP claimed
US-20250032371-A1 ETHANOL-FREE FRAGRANCE CHASSIS COTY INC. 2025-01-30 US claimed
EP-3624762-B1 PERFUMING COMPOSITIONS GIVAUDAN SA (CH) 2025-01-08 EP claimed
US-20250000778-A1 CHELANT AND CYCLODEXTRIN COMPOSITIONS COTY INC. 2025-01-02 US claimed
WO-2017136370-A1 COMPOSITIONS CONTAINING ANTIFOAMS THE PROCTER & GAMBLE COMPANY (US) 2017-08-10 WO claimed
EP-1898865-B1 FRAGANCE COMPOSITIONS GIVAUDAN NEDERLAND SERVICES B (NL) 2010-04-21 EP claimed
US-20090208437-A1 GLYCOPYRROLATE IN COSMETIC PREPARATIONS BEIERSDORF AG (DE) 2009-08-20 US claimed
US-20080255024-A1 Mixture containing relaxing odors QUEST INTERNATIONAL B.V. 2008-10-16 US claimed
EP-1898865-A1 FRAGANCE COMPOSITIONS Quest International Services B.V. (NL) 2008-03-19 EP claimed
EP-1343466-B1 PERFUME COMPOSITIONS QUEST INT SERV BV (NL) 2007-01-03 EP claimed
WO-2006136828-A1 FRAGANCE COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-12-28 WO claimed
US-20040063604-A1 Perfume compositions QUEST INTERNATIONAL B.V. (NL) 2004-04-01 US claimed
EP-1343466-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 2003-09-17 EP claimed
WO-2002049600-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 2002-06-27 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032371-A1 ETHANOL-FREE FRAGRANCE CHASSIS OR51E2, FDFT1, ELANE ALDH1A1 694/4885LMNA 4133/4885KDM4E 3144/4885
US-20090208437-A1 GLYCOPYRROLATE IN COSMETIC PREPARATIONS GYPA, TPO, DDT ALDH1A1 2004/4885LMNA 4791/4885KDM4E 3658/4885
US-20260013536-A1 FLAVOR COMPOSITION AND FOOD OR BEVERAGE EBP, FABP7, FABP2 ALDH1A1 1344/4885LMNA 1010/4885KDM4E 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.